Sort
48,018 grants matching “immunotherapy”
Project 2: Radiation-Induced Lymphopenia: Understanding, Predictive Modeling and Developing Photon and Proton-Based Mitigation Strategies.
$558,368Steven Hsesheng Lin · Massachusetts General Hospital · P01 · FY2025 · CA
Clinical production of viral vectors for cancer gene therapy
$558,354Steven Feldman · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA
Molecular Genetics
$558,342Carlo M Croce · University Of California, San Diego · P01 · FY2012 · CA
Project 3: Combinatorial and gene-editing approaches to enhance the efficacy of CAR T cell therapy of multiple myeloma.
$558,338Edward A Stadtmauer · University Of Pennsylvania · P01 · FY2019 · CA
Non-invasive imaging of the anti-tumor immune response
$558,258Hidde L Ploegh · Boston Children'S Hospital · R01 · FY2024 · CA
Role of heat shock transcription factor HSF1 in tumorigenesis
$558,195Nahid F Mivechi · Augusta University · R01 · FY2021 · CA
Role of heat shock transcription factor HSF1 in tumorigenesis
$558,195Nahid F Mivechi · Augusta University · R01 · FY2023 · CA
A Mechanoimmunological Basis for Metastatic Site Preference
$558,034Morgan A Huse · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Lung Cancer Care Outcomes/Surveillance Consortium-Iowa
$557,952University Of Iowa · U01 · FY2002 · CA
Molecular mechanism of antigen editing by Class-I MHC Chaperones
$557,933Nikolaos Sgourakis · Children'S Hosp Of Philadelphia · R01 · FY2020 · AI
Nanoconjugate delivery of proliferation and checkpoint inhibitors to treat glial tumors
$557,887Julia Y Ljubimova · Cedars-Sinai Medical Center · R01 · FY2016 · CA
Immunotherapeutic Modulation of Peanut Allergy
$557,860Scott H Sicherer · Icahn School Of Medicine At Mount Sinai · U19 · FY2009 · AI
Project 1: Promoting Graft-versus-Tumor Effects in the Bone Marrow
$557,823Geoffrey Roger Hill · Fred Hutchinson Cancer Center · P01 · FY2022 · CA
CD8 T cell-dependent pathways leading to immunopathology in cutaneous leishmaniasis
$557,812Phillip A. Scott · University Of Pennsylvania · R01 · FY2024 · AI
CD8 T cell-dependent pathways leading to immunopathology in cutaneous leishmaniasis
$557,812Phillip A. Scott · University Of Pennsylvania · R01 · FY2022 · AI
CD8 T cell-dependent pathways leading to immunopathology in cutaneous leishmaniasis
$557,812Phillip A. Scott · University Of Pennsylvania · R01 · FY2023 · AI
Developing translationally-relevant genetically engineered mouse models of lung adenocarcinoma for investigations in cancer immunology
$557,766Nikhil Joshi · Yale University · R01 · FY2021 · CA
Developing translationally-relevant genetically engineered mouse models of lung adenocarcinoma for investigations in cancer immunology
$557,766Nikhil Joshi · Yale University · R01 · FY2022 · CA
Developing translationally-relevant genetically engineered mouse models of lung adenocarcinoma for investigations in cancer immunology
$557,766Nikhil Joshi · Yale University · R01 · FY2020 · CA
A novel population of PLZF+CD8+ regulatory T cells: phenotype and function
$557,738Vipin Kumar · University Of California, San Diego · R56 · FY2020 · AI
Development of a translational imaging tool as a predictive biomarker for anti-PD-1/PD-L1 immunotherapies
$557,734Michael John Evans · University Of California, San Francisco · R01 · FY2018 · EB
Immune Therapy for Brain Metastasis
$557,726Lucia Beatrice Jilaveanu · Yale University · R01 · FY2025 · CA
Clinical Analysis Of Disorders Of Hearing And Balance
$557,577Carmen Crowell Brewer · National Institute On Deafness And Other Communication Disorders · ZIA · FY2009 · DC
Development of a translational imaging tool as a predictive biomarker for anti-PD-1/PD-L1 immunotherapies
$557,470Michael John Evans · University Of California, San Francisco · R01 · FY2021 · EB
Escape from CAR T surveillance through lineage plasticity
$557,374Patricia A Ernst · University Of Colorado Denver · R01 · FY2025 · CA